APA (7th ed.) Citation

DA, R., F, R., BA, K., JR, V., M, N., J, Z., . . . TP, B. (2019). Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease. PloS one, 14(4), e0215004. https://doi.org/10.1371/journal.pone.0215004

Chicago Style (17th ed.) Citation

DA, Roby, et al. "Pharmacological Activation of the Nuclear Receptor REV-ERB Reverses Cognitive Deficits and Reduces Amyloid-β Burden in a Mouse Model of Alzheimer's Disease." PloS One 14, no. 4 (2019): e0215004. https://doi.org/10.1371/journal.pone.0215004.

MLA (9th ed.) Citation

DA, Roby, et al. "Pharmacological Activation of the Nuclear Receptor REV-ERB Reverses Cognitive Deficits and Reduces Amyloid-β Burden in a Mouse Model of Alzheimer's Disease." PloS One, vol. 14, no. 4, 2019, p. e0215004, https://doi.org/10.1371/journal.pone.0215004.